undamentalytics Newsletter

Core Scientific, Inc. income statement

In fiscal 2025, Core Scientific, Inc. reported revenue of $319m, down 37.5% on the year before, operating income of −$246m (a -77.0% margin) and net income of −$289m, or −$0.88 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Core Scientific, Inc.: income statement, annual
Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue60544640502511319440
Cost of revenue51306632379390281316
Gross profit9239812312138125
Research and development5827712——
Selling, general and administrative———108114159152
Selling and marketing2413————
General and administrative1560213————
Operating income−6131−2,1109−142−246−561
Income before tax−1263−2,163−246−1,437−288−1,428
Income tax016−171113
Net income−1247−2,146−246−1,438−289−1,431
Diluted EPS−$0.14$0.20−$6.30−$0.65−$4.87−$0.88−$4.62
Diluted shares (average)158m233m341m380m256m318m310m
EBITDA3165−1,884105−29−177−499

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CORZ vs FVRRCORZ vs FUFUCORZ vs NBISCORZ vs HUT

More: Internet Services & Infrastructure stocks compared, Technology sector, rankings of US companies

Figures from Core Scientific, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Core Scientific, Inc.